Severe IgE-mediated food allergy research hub

Short-Term Linvoseltamab Treatment, on Top of Chronic Dupilumab Treatment, for Adults with Severe Immunoglobulin E (IgE)-Mediated Food Allergy

This study is looking at a new medicine called Linvoseltamab for adults with severe food allergies. It's added to their usual Dupilumab treatment to see if it can reduce allergic reactions. This is an early-stage study to check how the new medicine works and if it's safe.